Andreas Zirlik/LinkedIn
Sep 8, 2025, 07:48
Andreas Zirlik Announces EAS Rare Lipid Disorders Course at 7th Cardio Summit Graz
Andreas Zirlik, Head of the Department of Cardiology at LKH-University Hospital Graz, Medical University of Graz, and Chairman of the University Heart Center Graz, has shared a post on LinkedIn:
“EAS Advanced Course on the Topic of Rare Lipid Disorders, this year for the first time on 11th September 2025 as a pre-congress of the 7th Cardio Summit Graz.
Become a lipid expert interacting with our fantastic faculty, including Elisabeth Steinhagen-Thiessen, Winfried März, Herrmann Toplak, Alexander Peikert, Harald Sourij, Martin Clodi, Thomas Stulnig, and Eva Buschmann.
Register for free under [email protected].”
Learn more about the program here.
Stay informed with Hemostasis Today.
-
Sep 8, 2025, 07:48Andreas Zirlik Announces EAS Rare Lipid Disorders Course at 7th Cardio Summit Graz
-
Sep 8, 2025, 06:22Noa Kabera Joins EAHAD as Project Coordinator to Advance Haemophilia and Allied Disorders Care
-
Sep 7, 2025, 16:14Paddy Barret on Thin Cap Fibroatheroma's Outcomes
-
Sep 7, 2025, 14:17Edina Cenko Shares Lancet Regional Health Series on Inequalities in Cardiovascular Care
-
Sep 7, 2025, 14:04Pedal Circulation Status Found Crucial for Wound Healing in Chronic Limb-Threatening Ischemia
-
Sep 8, 2025, 14:22GLP-1 Receptor Agonists and Cardiovascular Benefits․ Role of Clinical Features
-
Sep 8, 2025, 14:21Hamza A. Salim: CTA Collateral Impairment Score Enhances Stroke Prognosis Accuracy
-
Sep 7, 2025, 17:19Tessa Jaspers and Colleagues on Current Evidence Not Supporting Routine Anti-Xa Monitoring in Use of LMWH
-
Sep 7, 2025, 14:11New RPTH Journal Research: Statins Reduce Thrombosis Risk but Not Severity of Pulmonary Embolism
-
Sep 7, 2025, 13:37Unfractionated Heparin Dosing in ECMO: A Systematic Review and Meta-Analysis
-
Sep 8, 2025, 14:24Von Willebrand Factor as a Therapeutic Target․ From Development to Clinical Application
-
Sep 7, 2025, 14:16Mary Kiige: Biological Hemoglobin Oxygen Carrier as a Lifesaving Oxygen Bridge
-
Sep 7, 2025, 14:13Breakthrough in Blood: Cécile Denis and INSERM Team Develop Nanobody Therapy for Type 1 VWD
-
Sep 2, 2025, 13:53Cost-Effective Strategies to Reduce Anaemia Highlighted in The Lancet Haematology
-
Sep 2, 2025, 13:04Ischemic Stroke or TIA Linked to Higher Femoral Fracture Risk
-
Sep 8, 2025, 15:10Michael Makris on WHO’s Essential Medicines List Update: A Win for the Global Haemophilia Community
-
Sep 8, 2025, 14:26European Haemophilia Consortium Marks World PT Day: Physiotherapy Empowers People with Bleeding Disorders
-
Sep 8, 2025, 07:03Omar Adwan Explains the Key Difference Between Serum and Plasma
-
Sep 8, 2025, 05:27Kerry Bozza Funkhouser at BIC 2025 Roundtable on Heavy Menstrual Bleeding and Rare Bleeding Disorders
-
Sep 7, 2025, 17:30Louise Bannon Invites You To Join The ''Blood Clot Busters'' Series Uncovering The Truth About Thrombosis
Sep 8, 2025, 07:03